The purpose of this study is to assess the efficacy of AX200 (filgrastim) in the treatment of acute ischemic stroke and to assess the safety and tolerability of AX200.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
328
135 μg/kg body weight total dose Short term infusion (20 to 30 minutes) and continuous infusion over 3 days
Short term infusion (20 to 30 minutes) and continuous infusion over 3 days
Improvement on mRS relative to placebo-treated patients
Time frame: day 90
Improvement on NIHSS relative to placebo-treated patients
Time frame: day 90
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Landes-Nervenklinik Wagner-Jauregg
Linz, Austria
AHK Linz
Linz, Austria
Wilhelminenspital
Vienna, Austria
AZ Sint-Jan AV
Bruges, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
UZ Gasthuisberg
Leuven, Belgium
St. Anne's Faculty Hospital
Brno, Czechia
Faculty Hospital
Olomouc, Czechia
Faculty Hospital Ostrava
Ostrava, Czechia
...and 48 more locations